Search clinical trials for: LAAM. buprenorphine and methadone

Total 810 results

Mundipharma Research Limited

Completed

Bioequivalence and Adhesion Comparison of Buprenorphine Patches

Pain

United Kingdom
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dosing Interval - 5

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase IV - 5

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VI - 7

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Gradual Vs. Rapid Buprenorphine Detoxification - 2

Opioid-Related Disorders

United States
Istituto Ortopedico Rizzoli

Completed

Evaluation of Ankle Propriocement and Stability (ANKLE-INT)

Ankle Sprains | Instability, Joint

Italy
USWM, LLC (dba US WorldMeds)

Completed

Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction

Substance Withdrawal Syndrome | Opiate Dependence | Opiate Addiction

United States
Wei Zhao
Beijing Children's Hospital

Unknown

A Study the Population Pharmacokinetics of Children of Infectious Disease in Central Nervous System

Central Nervous System Infection

China
Rigshospitalet, Denmark
Abbott; Feops

Unknown

Computational Simulation to Plan for Percutaneous Left Atrial Appendage Closure

Atrial Fibrillation | Stroke Prevention

Denmark, Spain, Sweden, Belgium, Canada, France, Italy
Salem Anaesthesia Pain Clinic

Recruiting

Kratom Use Disorder Management Using Clonidine and/or Buprenorphine

Withdrawal Syndrome

Canada
The University of Texas Health Science Center,...

Recruiting

Young Houston Emergency Opioid Engagement System (YHEROES)

Substance Use Disorders | Opioid Dependence | Opioid Use | Opioid-use Disorder | Opioid Overdose

United States
Kuopio University Hospital
University of Eastern Finland

Completed

Effects of Low Dose Buprenorphine on Recovery After Hip or Knee Arthroplasty (lonkkalaasta)

Pain | Osteoarthritis

Finland
Purdue Pharma LP

Completed

Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee

Chronic Pain | Osteoarthritis of the Knee

United States
New York State Psychiatric Institute
Schering-Plough

Completed

Abuse Liability of Suboxone Versus Subutex

Opioid-related Disorders

United States
Boehringer Ingelheim

Terminated

Pramipexole ER vs. Placebo in Fibromyalgia

Fibromyalgia

United States
Aurora Quaye
MaineHealth

Terminated

The Effect of Buprenorphine Continuation for Patients With Opioid Use Disorder

Opioid-use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 2

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 3

Opioid-Related Disorders

United States
Virginia Commonwealth University

Completed

Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal

Drug Overdose | Opioid-use Disorder | Opioid Withdrawal

United States
University of Pittsburgh
National Institutes of Health (NIH); National Center for Research Resources... and other collaborators

Completed

Buprenorphine for Late-Life Treatment Resistant Depression (BUILD)

Depression

United States
National Institute on Drug Abuse (NIDA)
Cincinnati MDRU

Completed

Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Buprenorphine Maintenance for Opiate Dependence - 6

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Liquid vs. Tablet Buprenorphine - 6

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Mclean Hospital

Completed

Treatment Efficacy for Drug Abuse and AIDS Prevention - 2

Heroin Dependence | Cocaine-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detox With Two Types of Treatment. BBD II - 11

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate-Day Buprenorphine Administration. Phase VIII - 9

Opioid-Related Disorders

United States
Mundipharma Korea Ltd

Completed

An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders (NOBLE)

Spinal Disorder

Korea, Republic of
National Institute on Drug Abuse (NIDA)

Completed

Study Comparing Liquid and Tablet Buprenorphine Formulations - 5

Heroin Dependence

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase X - 15

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detox With Two Types of Treatment. BBD I - 10

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase II - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VII - 8

Opioid-Related Disorders

United States
Nationwide Children's Hospital

Completed

Methadone vs Magnesium in Spinal Fusion

Idiopathic Scoliosis

United States
University of British Columbia
British Columbia Cancer Agency

Not yet recruiting

Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy (METACIN)

Chemotherapy-induced Peripheral Neuropathy
Novartis

Terminated

Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.

Opioid-induced Constipation

United States
Linkoeping University
Armauer Hansen Research Institute, Ethiopia; University of Gondar

Completed

Deworming Against Tuberculosis

Tuberculosis

Ethiopia
Brigham and Women's Hospital
University of Utah

Not yet recruiting

Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder

Opioid Use Disorder
University Hospital, Clermont-Ferrand

Active, not recruiting

High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid (SEVROP)

High Dosage Buprenorphine

France
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 1

Opioid-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care

Substance Abuse, Intravenous | Opioid-Related Disorders | Heroin Dependence

United States
Mundipharma Research Limited

Terminated

A Study to Characterize the Pharmacokinetics and Tolerability of Buprenorphine Patches in Children With Moderate to Severe Mouth Pain (BUP1501)

Chemotherapy Induced Mucositis | Mouth Pain

Denmark, United Kingdom
Chong Kun Dang Pharmaceutical

Completed

CKD-337 Drug Interaction Study

Dyslipidemia (Fredrickson Type Ⅱa) | Dyslipidemia (Fredrickson Type Ⅱb)

Korea, Republic of
National Institute on Drug Abuse (NIDA)

Completed

Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance Protocol - 1

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Multicenter Clinical Trial of Buprenorphine - 3

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase XI - 16

Opioid-Related Disorders

United States

Search clinical trials for: LAAM. buprenorphine and methadone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations